CNN/Money One for credit card only hard offer form at $9.95 One for risk-free form at $14.95 w/ $9.95 upsell  
News > Fortune 500
Excedrin brand for sale
Bristol-Myers Squibb seeking buyer for U.S. and Canadian consumer medicines.
January 12, 2005: 11:49 AM EST

NEW YORK (Reuters) - Bristol-Myers Squibb Co. said Wednesday it plans to divest its U.S. and Canadian consumer medicines, including its Excedrin painkiller, in a move that would tighten its U.S. focus on sales of more-profitable prescription drugs.

The New York-based drugmaker said it will contact potential buyers in coming weeks, but that it will keep its consumer medicines in Japan, China, Latin America, Europe, Middle East and Africa. Recent published reports have said the company was considering sale of its consumer brands in North America.  Top of page

  More on NEWS
JPMorgan dramatically slashes Tesla's stock price forecast
Greece is finally done with its epic bailout binge
Europe is preparing another crackdown on Big Tech
7 things to know before the bell
SoftBank and Toyota want driverless cars to change the world
Aston Martin falls 5% in its London IPO

graphic graphic